MGMT and glioblastoma: Using Cox proportional hazard ratios test, we found that in GBM patients, poor overall prognosis with high MR1 expression was irrespective of confounding factors such as age, gender, MGMT promoter methylation status, and IDH mutation status (Supplementary Table 2, HR: 1.308, P < .004).